Cite

HARVARD Citation

    Dillon, A. et al. (n.d.). OUTCOMES OF DOSE ESCALATION WITH ADALIMUMAB (ADA) IN INFLAMMATORY BOWEL DISEASE. Gut. pp. A42-A43. [Online]. 
  
Back to record